UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

THU0061 Anemia in patients with rheumatoid arthritis: A cross-sectional study

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.173-173

2013

Volltextzugriff (PDF)

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients

Blood, 2011-07, Vol.118 (2), p.401-408

2011

Volltextzugriff (PDF)

High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron

Vox sanguinis, 2010-11, Vol.99 (4), p.354-361

2010

Volltextzugriff (PDF)

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease

Journal of clinical oncology, 2016-01, Vol.34 (2), p.151-159

2016

Volltextzugriff (PDF)

Anagrelide Treatment in Myeloproliferative Disorders

Seminars in thrombosis and hemostasis, 2006-04, Vol.32 (3), p.260-266

Birgegard, Gunnar

2006

Volltextzugriff (PDF)

Does anything work for anaemia in myelofibrosis?

Best practice & research. Clinical haematology, 2014-06, Vol.27 (2), p.175-185

Birgegard, Gunnar

2014

Volltextzugriff (PDF)

Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial

Journal of clinical nursing, 2010-08, Vol.19 (15-16), p.2146-2151

2010

Volltextzugriff (PDF)

CIRCADIAN VARIATION OF GRANULOCYTE COLONY‐STIMULATING FACTOR LEVELS IN MAN

British journal of haematology, 2000-03, Vol.108 (3), p.661-661

Birgegard, Gunnar

2000

Volltextzugriff (PDF)

Quality of life, physical function and MRI T2in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions

European journal of haematology, 2011-09, Vol.87 (3), p.244

2011

Volltextzugriff (PDF)

Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety study

Haematologica (Roma), 2014-04, Vol.99 (4), p.679-687

2014

Volltextzugriff (PDF)

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

Haematologica (Roma), 2017-01, Vol.102 (1), p.85-93

2017

Volltextzugriff (PDF)

A phase II trial of pegylated interferon α-2b therapy for polycythemia vera and essential thrombocythemia : Feasibility, clinical and biologic effects, and impact on quality of life

Cancer, 2006-06, Vol.106 (11), p.2397-2405

2006

Volltextzugriff (PDF)

Rapid detection of erythropoiesis-stimulating agents in urine and serum

Analytical biochemistry, 2012-01, Vol.420 (2), p.101-114

2012

Volltextzugriff (PDF)

Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders

Haematologica (Roma), 2004, Vol.89 (5), p.520

2004

Volltextzugriff (PDF)

Treatment of high risk ET – data from the EXELS study

Leukemia research, 2016-05, Vol.44, p.S7-S8

2016

Volltextzugriff (PDF)

Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation

British journal of haematology, 1989-07, Vol.72 (3), p.462-466

1989

Volltextzugriff (PDF)

PSY98 - COST-EFFECTIVENESS ANALYSIS OF FERRIC MALTOL VERSUS FERRIC CARBOXYMALTOSE FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN IBD PATIENTS IN SWEDEN AND FINLAND

Value in health, 2018-10, Vol.21, p.S452-S453

2018

Volltextzugriff (PDF)

MED NORD-A tool for measuring medical students' well-being and study orientations

Medical teacher, 2008-01, Vol.30 (1), p.72-79

2008

Volltextzugriff (PDF)

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET

Leukemia, 2015-01, Vol.29 (1), p.20

2015

Volltextzugriff (PDF)

Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced‐intensity conditioning regimens

British journal of haematology, 2006-11, Vol.135 (3), p.367-373

2006

Volltextzugriff (PDF)

Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up

Hematology (Luxembourg), 2013-01, Vol.18 (1), p.8-13

2013

Volltextzugriff (PDF)

Circadian rhythm of erythropoietin in human serum

British journal of haematology, 1989-05, Vol.72 (1), p.85-90

1989

Volltextzugriff (PDF)

Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia

Haematologica (Roma), 2006-09, Vol.91 (9), p.1281-1282

2006

Volltextzugriff (PDF)

Evaluation of beta Globin mRNA as an Early Marker of Hb Response to Epoetin Treatment

BLOOD, 2006, Vol.108 (11), p.3750-3750

2006

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(116)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

THU0061 Anemia in patients with rheumatoid arthritis: A cross-sectional study

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patients

High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron

Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patients

Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease

Anagrelide Treatment in Myeloproliferative Disorders

Does anything work for anaemia in myelofibrosis?

Oral cryotherapy reduces mucositis and improves nutrition - a randomised controlled trial

CIRCADIAN VARIATION OF GRANULOCYTE COLONY‐STIMULATING FACTOR LEVELS IN MAN

Quality of life, physical function and MRI T2in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions

Combination therapy of hydroxycarbamide with anagrelide in patients with essential thrombocythemia in the evaluation of Xagrid(R) efficacy and long-term safety study

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group

A phase II trial of pegylated interferon α-2b therapy for polycythemia vera and essential thrombocythemia : Feasibility, clinical and biologic effects, and impact on quality of life

Rapid detection of erythropoiesis-stimulating agents in urine and serum

Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders

Treatment of high risk ET – data from the EXELS study

Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation

PSY98 - COST-EFFECTIVENESS ANALYSIS OF FERRIC MALTOL VERSUS FERRIC CARBOXYMALTOSE FOR THE TREATMENT OF IRON DEFICIENCY ANAEMIA IN IBD PATIENTS IN SWEDEN AND FINLAND

MED NORD-A tool for measuring medical students' well-being and study orientations

Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET

Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced‐intensity conditioning regimens

Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: Results of a prospective long-term follow-up

Circadian rhythm of erythropoietin in human serum

Limited effects on JAK2 mutational status after pegylated interferon alpha-2b therapy in polycythemia vera and essential thrombocythemia

Evaluation of beta Globin mRNA as an Early Marker of Hb Response to Epoetin Treatment

Aktive Filter

Suchergebnisse filtern